According to Vasta Platform's latest financial reports the company has a price-to-book ratio of 0.3130.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 0.3947 | 4.63% |
2022-12-31 | 0.3772 | -9.35% |
2021-12-31 | 0.4161 | -68.13% |
2020-12-31 | 1.31 | |
2019-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Verastem Oncology
VSTM | 5.35 | 1,610.39% | ๐บ๐ธ USA |
Spectrum Pharmaceuticals
SPPI | 7.89 | 2,419.33% | ๐บ๐ธ USA |
Emergent BioSolutions
EBS | 0.4253 | 35.86% | ๐บ๐ธ USA |